Wall St. Icon: “If you wait on this, it will already be too late”

If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.

Thomas Farrington net worth and biography

Thomas Farrington Biography and Net Worth

EVP of Perrigo

Mr. Farrington was named Executive Vice President and Chief Information Officer in November 2015. He formerly served as Senior Vice President and Chief Information Officer from October 2006 to November 2015. Before that, he served as Chief Information Officer for F. Dohmen Co. in addition to serving as a division President for JASCORP LLC from March 2003 to October 2006. Mr. Farrington is also a director of the American Lung Association, Midland States.

What is Thomas Farrington's net worth?: The estimated net worth of Thomas Farrington is at least $72,381.72 as of March 13th, 2023. Mr. Farrington owns 2,823 shares of Perrigo stock worth more than $72,382 as of December 24th. This net worth evaluation does not reflect any other assets that Mr. Farrington may own. Learn More about Thomas Farrington's net worth.
How do I contact Thomas Farrington?: The corporate mailing address for Mr. Farrington and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Thomas Farrington's contact information.
Has Thomas Farrington been buying or selling shares of Perrigo?: Thomas Farrington has not been actively trading shares of Perrigo during the past quarter. Most recently, Thomas Farrington sold 3,723 shares of the business's stock in a transaction on Monday, March 13th. The shares were sold at an average price of $35.57, for a transaction totalling $132,427.11. Following the completion of the sale, the executive vice president now directly owns 2,823 shares of the company's stock, valued at $100,414.11. Learn More on Thomas Farrington's trading history.
Who are Perrigo's active insiders?: Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Patrick Lockwood-Taylor (President, CEO & Director), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.
Are insiders buying or selling shares of Perrigo?: During the last twelve months, Perrigo insiders bought shares 4 times. They purchased a total of 18,990 shares worth more than $503,127.40. During the last twelve months, insiders at the sold shares 4 times. They sold a total of 67,852 shares worth more than $1,909,464.66. The most recent insider tranaction occured on December, 9th when Director Jeffrey B Kindler sold 17,598 shares worth more than $497,495.46. Insiders at Perrigo own 0.4% of the company. Learn More about insider trades at Perrigo.
Information on this page was last updated on 12/9/2024.

Thomas Farrington Insider Trading History at Perrigo

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/13/2023	Sell	3,723	$35.57	$132,427.11	2,823
3/14/2022	Sell	24,485	$37.13	$909,128.05
11/16/2017	Sell	213	$87.26	$18,586.38	3,347
8/30/2017	Sell	616	$76.90	$47,370.40	2,724
8/18/2017	Sell	865	$78.40	$67,816.00	2,870
9/26/2016	Sell	1,110	$96.76	$107,403.60	2,970
9/2/2014	Sell	1,741	$150.36	$261,776.76
8/20/2013	Sell	1,658	$119.86	$198,727.88	1,040

Thomas Farrington Buying and Selling Activity at Perrigo

Perrigo Company Overview

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Today's Range

Now: $25.64

$25.50

$25.74

50 Day Range

MA: $26.75

$24.40

$28.91

2 Week Range

Now: $25.64

$23.89

$34.60

Volume

499,124 shs

Average Volume

1,594,669 shs

Market Capitalization

$3.50 billion

P/E Ratio

N/A

Dividend Yield

4.29%

Beta

0.52

Wall St. Icon: “If you wait on this, it will already be too late”

From InvestorPlace | Ad